OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 128 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $2,300,000 | -69.1% | 4,086,988 | -5.5% | 0.00% | -75.0% |
| Q4 2015 | $7,438,000 | -18.5% | 4,324,500 | 0.0% | 0.00% | -20.0% |
| Q3 2015 | $9,125,000 | -46.5% | 4,324,500 | +25.5% | 0.01% | -37.5% |
| Q2 2015 | $17,058,000 | -36.8% | 3,446,000 | 0.0% | 0.01% | -33.3% |
| Q1 2015 | $26,982,000 | +24.5% | 3,446,000 | -3.6% | 0.01% | +20.0% |
| Q4 2014 | $21,669,000 | +26.5% | 3,575,800 | -11.1% | 0.01% | +25.0% |
| Q3 2014 | $17,129,000 | -24.1% | 4,020,877 | +10.1% | 0.01% | -20.0% |
| Q2 2014 | $22,566,000 | -13.8% | 3,651,477 | -9.3% | 0.01% | -16.7% |
| Q1 2014 | $26,182,000 | +100.1% | 4,027,977 | +73.3% | 0.01% | +100.0% |
| Q4 2013 | $13,087,000 | +7.3% | 2,324,500 | +17.1% | 0.01% | 0.0% |
| Q3 2013 | $12,192,000 | +33.1% | 1,985,700 | +26.8% | 0.01% | +20.0% |
| Q2 2013 | $9,158,000 | – | 1,565,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,250,000 | $7,725,000 | 6.48% |
| Ghost Tree Capital, LLC | 250,000 | $1,545,000 | 1.09% |
| Rock Springs Capital Management LP | 905,000 | $5,593,000 | 1.00% |
| Palo Alto Investors LP | 1,931,324 | $11,936,000 | 0.89% |
| PFM Health Sciences, LP | 4,604,958 | $28,459,000 | 0.57% |
| NEA Management Company, LLC | 1,935,300 | $11,960,000 | 0.56% |
| Rhenman & Partners Asset Management AB | 300,199 | $1,855,000 | 0.55% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 1,752,792 | $10,832,000 | 0.50% |
| CQS Cayman LP | 660,040 | $4,079,000 | 0.25% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,684,300 | $16,589,000 | 0.24% |